We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

This study has been terminated.
(Study was terminated due to patient complications unrelated to study drugs)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01279187
First Posted: January 19, 2011
Last Update Posted: December 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Jill Bashutski, University of Michigan
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)